News & Analysis on the Global Animal Feed and Pet Food Industries
The funding from that strategic investor is part of an initial unpriced round to support Entoprotech’s R&D and business development plans in the next 12 months and will be part of a $30m Series A round planned towards Q4 2022.
The partners are aiming to raise productivity of the animal protein value chain in that Asian country.
DSM is transforming its business, creating a separate animal nutrition and health division, as part of that the process, and it is also starting a review of strategic options for its materials unit, including a possible change of ownership.